MX346576B - Metodos y composiciones adecuados para promover piel sana. - Google Patents

Metodos y composiciones adecuados para promover piel sana.

Info

Publication number
MX346576B
MX346576B MX2013004689A MX2013004689A MX346576B MX 346576 B MX346576 B MX 346576B MX 2013004689 A MX2013004689 A MX 2013004689A MX 2013004689 A MX2013004689 A MX 2013004689A MX 346576 B MX346576 B MX 346576B
Authority
MX
Mexico
Prior art keywords
methods
agents
healthy skin
promoting healthy
compositions suitable
Prior art date
Application number
MX2013004689A
Other languages
English (en)
Spanish (es)
Other versions
MX2013004689A (es
Inventor
Pan Yuanlong
Paul Middleton Rondo
Scott Hannah Steven
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013004689A publication Critical patent/MX2013004689A/es
Publication of MX346576B publication Critical patent/MX346576B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
MX2013004689A 2010-10-27 2011-10-21 Metodos y composiciones adecuados para promover piel sana. MX346576B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45584110P 2010-10-27 2010-10-27
PCT/US2011/001795 WO2012057824A1 (en) 2010-10-27 2011-10-21 Methods and compositions suitable for promoting healthy skin

Publications (2)

Publication Number Publication Date
MX2013004689A MX2013004689A (es) 2013-06-12
MX346576B true MX346576B (es) 2017-03-24

Family

ID=45994276

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004689A MX346576B (es) 2010-10-27 2011-10-21 Metodos y composiciones adecuados para promover piel sana.

Country Status (11)

Country Link
US (1) US9301973B2 (enExample)
EP (1) EP2632414A4 (enExample)
JP (1) JP6301655B2 (enExample)
CN (1) CN103282013B (enExample)
AU (1) AU2011320994B2 (enExample)
BR (1) BR112013010556A2 (enExample)
CA (1) CA2816054A1 (enExample)
MX (1) MX346576B (enExample)
RU (1) RU2605330C2 (enExample)
WO (1) WO2012057824A1 (enExample)
ZA (1) ZA201303810B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2821807A1 (en) * 2010-12-21 2012-06-28 Nestec S.A. Methods and compositions suitable for managing blood glucose in animals
US9468609B2 (en) * 2013-03-19 2016-10-18 Lycored Ltd. Astaxanthin anti-inflammatory synergistic combinations
TW201513851A (zh) * 2013-03-27 2015-04-16 Jx Nippon Oil & Energy Corp 抗炎症藥
CN103961276A (zh) * 2014-01-08 2014-08-06 片仔癀（上海）生物科技研发有限公司 抗糖化化妆品组合物及含其的抗糖化化妆品
JP2015159774A (ja) * 2014-02-28 2015-09-07 不二製油株式会社 接触性皮膚炎を抑制する食品添加用組成物
KR101640744B1 (ko) 2014-05-07 2016-07-19 일동제약주식회사 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도
CN104162143B (zh) * 2014-08-01 2016-08-31 南阳医学高等专科学校 眼表保护剂及其制备方法
WO2016092479A1 (en) * 2014-12-10 2016-06-16 Subramaniam Vanangamudi Sulur A pharmaceutical formulation comprising resveratrol, benfotiamine and pyridoxamine, a process of making it and a method of treatment using it
JP2016185939A (ja) * 2015-03-27 2016-10-27 ロート製薬株式会社 経口組成物
CN106331037B (zh) * 2015-06-30 2023-09-19 邻元科技（北京）有限公司 用于分布式计算网络的计算节点
US10842169B2 (en) * 2015-09-30 2020-11-24 Hill's Pet Nutrition, Inc. Pet food composition for managing non-food allergies
CN106617064A (zh) * 2016-12-22 2017-05-10 徐晓飞 一种含姜黄素和ω‑3多不饱和脂肪酸的组合物及其应用
CN107469066A (zh) * 2017-08-23 2017-12-15 上海新肌生物科技有限公司 一种消除98%糖化反应链发生源的源头型抗糖化配方
CN108048392B (zh) * 2018-01-31 2021-04-06 成都艾伟孚生物科技有限公司 一种一步式胚胎培养液及其制备方法
CN109897820B (zh) * 2019-03-25 2022-03-04 内蒙古大学 一种延缓体外培养卵子老化的方法
US20210315930A1 (en) * 2020-04-14 2021-10-14 David A. Cuddeback Nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation
US20230404902A1 (en) * 2022-06-15 2023-12-21 Jamrm, Llc Skincare Composition Utilizing a Metabolomics Guided, Bioprocess Engineered Sunflower Sprout Active

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03169813A (ja) * 1989-11-09 1991-07-23 Asta Pharma Ag 細胞保護作用を有する疼痛及び炎症性疾患及び／又はレトロウイルスに起因する病気の治療用医薬並びにその製法
JPH03197429A (ja) * 1989-12-26 1991-08-28 Tetsuo Nakamura 鎮痛抗炎症剤
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
AU693312B2 (en) * 1995-01-18 1998-06-25 Taisho Pharmaceutical Co., Ltd. Remedy for dermatitis
FR2833174B1 (fr) * 2001-12-06 2004-05-28 Margaret Bronnert Pommade grasse d'origine animale destinee a soulager des demangeaisons et irritations de la peau dues aux dermites, eczema atopique et psoriasis,secheresse cutanee et hyperkeratinose
US6932987B1 (en) * 2002-05-29 2005-08-23 Jose A. Diaz Chemical composition and method for enhancing metabolism
RU2233160C2 (ru) * 2002-09-24 2004-07-27 Матусевич Сергей Львович Способ лечения псориаза
US6887497B2 (en) * 2002-12-19 2005-05-03 Vitacost.Com, Inc. Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function
WO2004096119A2 (en) * 2003-04-30 2004-11-11 Dr. Eger - Olive Oil Products Industry Ltd. Topical pharmaceutical compositions, methods of manufacture thereof and articles of manufacture containing same
RU2350124C2 (ru) 2004-01-28 2009-03-27 Нестек С.А. Питательная композиция для улучшения состояния кожи и предотвращения кожных заболеваний
US7390507B2 (en) * 2004-04-13 2008-06-24 Ruwart Mary J Compositions and methods for the treatment of radiation burns and other traumatic skin conditions
US20080033027A1 (en) 2005-03-21 2008-02-07 Vicus Therapeutics Spe 1, Llc Drug combination pharmaceutical compositions and methods for using them
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20070231371A1 (en) * 2006-02-01 2007-10-04 Nestec, S. A. Nutritional system and methods for increasing longevity
WO2008119012A2 (en) * 2007-03-27 2008-10-02 The Procter & Gamble Company Methods and kits for administering probiotics
ES2316312B1 (es) * 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.

Also Published As

Publication number Publication date
EP2632414A1 (en) 2013-09-04
CA2816054A1 (en) 2012-05-03
US20130209583A1 (en) 2013-08-15
RU2013124032A (ru) 2014-12-10
AU2011320994A1 (en) 2013-05-23
MX2013004689A (es) 2013-06-12
WO2012057824A1 (en) 2012-05-03
CN103282013B (zh) 2016-10-26
US9301973B2 (en) 2016-04-05
CN103282013A (zh) 2013-09-04
EP2632414A4 (en) 2014-03-12
RU2605330C2 (ru) 2016-12-20
JP6301655B2 (ja) 2018-03-28
AU2011320994B2 (en) 2016-08-25
ZA201303810B (en) 2014-11-26
BR112013010556A2 (pt) 2016-07-05
JP2013542222A (ja) 2013-11-21

Similar Documents

Publication Publication Date Title
MX346576B (es) Metodos y composiciones adecuados para promover piel sana.
WO2012087742A3 (en) Methods and compositions suitable for managing blood glucose in animals
IN2012DN06720A (enExample)
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
NZ700759A (en) Combination therapy for treating cancer
WO2012030984A3 (en) Skin compositions and methods of use thereof
MY166014A (en) Combination therapy methods for treating proliferative diseases
UA122342C2 (uk) Спосіб інгібування всмоктування та/або прискорення виведення ліпідів за допомогою d-псикози
GB201318761D0 (en) Compounds for the treatment of neuropsychiatric disorders
BR112013000433A2 (pt) diagnóstico e tratamento de câncer de mama
MX359453B (es) Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad.
SG10201805267UA (en) Piperazine derivatives having multimodal activity against pain
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
MX2015003074A (es) Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas.
MX2015010296A (es) Tratamiento de formas progresivas de esclerosis multiple con laquinimod.
PH12014500250A1 (en) Substituted 3-(biphenyl-3-yl)-4 -hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
AU2016216741A1 (en) Compositions and methods of use of an inappetance-controlling compound
MX342119B (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2013002121A (es) Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2016006603A (es) Compuestos piperidinicos con actividad multimodal contra el dolor.
TR201004464A2 (tr) Kemik erimesi için formülasyon.
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
IN2014DN09437A (enExample)
MX342459B (es) 2-oxo- y 2-tioxo-dihidroquinolin-3-carboxamidas sustituidas, como moduladores de kcnq2/3.

Legal Events

Date Code Title Description
FG Grant or registration